Research Article
lncRNA LINC00355 Acts as a Novel Biomarker and Promotes Glioma Biological Activities via the Regulation of miR-1225/FNDC3B
Table 2
The association between LINC00355 expression and clinicopathological factors in glioma patients.
| Parameters | Number | LINC00355 expression | | High | Low |
| Age | | | | 0.512 | <50 | 52 | 24 | 28 | | ≥50 | 69 | 36 | 33 | | Gender | | | | 0.409 | Male | 64 | 34 | 30 | | Female | 57 | 26 | 31 | | Tumor location | | | | 0.238 | Supratentorial | 60 | 33 | 27 | | Infratentorial | 61 | 27 | 34 | | Family history of cancer | | | | 0.410 | Yes | 44 | 24 | 20 | | No | 77 | 36 | 41 | | KPS | | | | 0.019 | ≥70 | 74 | 43 | 31 | | <70 | 47 | 17 | 30 | | Size | | | | 0.158 | <5 cm | 73 | 40 | 33 | | ≥5 cm | 48 | 20 | 28 | | WHO grade | | | | 0.024 | Low | 81 | 46 | 35 | | High | 40 | 14 | 26 | |
|
|